JPRN-UMIN000001754
Completed
Phase 2
Phase II trial neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma patients - Phase II trial neoadjuvant chemoradiation therapy with gemcitabine and surgical resection for advanced cholangiocarcinoma patients:NACRAC study
Hepato-biliary pancreatic surgery,Tohoku University Hospital0 sites40 target enrollmentMarch 4, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- cholangiocarecinoma:Stage III and IV of the Japanese General Rules for Surgical and Pathological Studies on Cancer of the Biliary Tract
- Sponsor
- Hepato-biliary pancreatic surgery,Tohoku University Hospital
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. obvious infection 2\. fever up (over 38 Celsius) 3\. severe complication of heart and lung 4\. active double cancer 5\. synptom of brain metastases 6\. pericardial fluid 7\. Previous history of severe drug\-induced allergy 8\. Pregnant 9\. Disqualified by attendig doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A phase II clinical trial of neoadjuvant chemoradiation therapy for pancreatic ductal adenocarcinomapancreatic cancerJPRN-UMIN000035232Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University50
Not yet recruiting
Not Applicable
Phase 2 clinical study of neoadjuvant chemotherapy for HER2-negative primary breast cancer patients using dose dense nab-paclitaxel followed by dose dense Epirubicin and cyclophosphamideHER2 negative primary breast cancerJPRN-UMIN000019787Dept of breast oncology50
Recruiting
Phase 2
A clinical phase-II trial of neoadjuvant chemoradiotherapy with S-1 and Gemcitabine for locally advanced pancreatic cancer (PerSeUS-GP02)ocally advanced pancreatic cancerJPRN-UMIN000010435PerSeUS: Perpetual Study estimated-by United Sections in gifu40
Completed
Phase 2
A clinical phase-II trial of neoadjuvant chemoradiation therapy using S-1 for locally advanced pancreatic cancer (PerSeUS-GP-01)ocally advanced pancreatic cancerJPRN-UMIN000002176PerSeUS-GP40
Completed
Not Applicable
Phase II trial as new adjuvant chemotherapy regimen for capecitabine in stage II and III colorectal cancer.StageII(high risk) and stageIIIa resectable colorectal cancerJPRN-UMIN000012813Tsukasa Hotta25